Mather Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.1K Buy
1,009
+660
+189% +$47.5K ﹤0.01% 1047
2026
Q2
$24.7K Sell
349
-152
-30% -$8.21K ﹤0.01% 1282
2026
Q1
$26.2K Buy
+501
New +$30.1K ﹤0.01% 1218
2025
Q4
– Sell
-217
Closed -$12.1K – 1545
2025
Q3
$12.1K Buy
+217
New +$11.6K ﹤0.01% 1228
2025
Q2
– Sell
-1,215
Closed -$71.2K – 1609
2025
Q1
$71.2K Buy
1,215
+534
+78% +$36.2K ﹤0.01% 835
2024
Q4
$49.1K Buy
681
+69
+11% +$5.07K ﹤0.01% 879
2024
Q3
$48.9K Buy
612
+208
+51% +$15.6K ﹤0.01% 883
2024
Q2
$28.4K Sell
404
-94
-19% -$6.92K ﹤0.01% 1168
2024
Q1
$38.4K Buy
+498
New +$35.6K ﹤0.01% 927

Other funds holding TECH

Mather Group's TECH Position: Q3 2026 in Review

Mather Group increased its Bio-Techne (TECH) stake by 189% in Q3 2026, buying an estimated $47.5K and bringing the position to 1,009 shares worth $73.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Mather Group first reported a position in TECH in Q1 2024 and has held it in 9 quarters since. 68 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Mather Group held 1,009 shares of Bio-Techne worth $73.1K as of Q3 2026.
  • Mather Group bought 660 Bio-Techne shares in Q3 2026, an estimated $47.5K.
  • Bio-Techne made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1047 holding.
  • Mather Group first reported a position in Bio-Techne in Q1 2024 and has held it in 9 quarters since.
  • 68 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.